L'Oréal Australia Pty Ltd v BrandPoint Pty Ltd

Link copied
Case Copied 26 min read

FEDERAL COURT OF AUSTRALIA

L’Oréal Australia Pty Ltd v BrandPoint Pty Ltd [2015] FCA 978

Citation: L’Oréal Australia Pty Ltd v BrandPoint Pty Ltd [2015] FCA 978
Parties: L’ORÉAL AUSTRALIA PTY LTD (ABN 40 004 191 673) v BRANDPOINT PTY LTD (ABN 12 135 694 718)
File number: VID 285 of 2015
Judge: BEACH J
Date of judgment: 4 September 2015
Catchwords: PRACTICE AND PROCEDURE – application for preliminary discovery – r 7.23 of the Federal Court Rules 2011 (Cth) – facial cleansing products – potentially misleading or deceptive conduct or false representations by prospective respondent to retailers and consumers – potential right to relief arising from alleged contraventions of ss 18 and 29 of the Australian Consumer Law – reasonableness of prospective applicant’s belief – whether reasonable inquiries made by prospective applicant – order for preliminary discovery made in part
Legislation: Competition and Consumer Act 2010 (Cth) sch 2, ss 18, 29
Federal Court Rules 2011 (Cth) r 7.23
Cases cited: Apache Northwest Pty Ltd v Newcrest Mining Ltd (2009) 182 FCR 124
AstraZeneca AB v Alphapharm Pty Ltd [2014] FCA 9
Australian Competition and Consumer Commission v TPG Internet Pty Ltd (2013) 250 CLR 640
Benchmark Certification Pty Ltd v Standards Australia International Ltd (2004) 212 ALR 464
Butcher v Lachlan Elder Realty Pty Ltd (2004) 218 CLR 592
Demagogue Pty Ltd v Ramensky (1992) 39 FCR 31
Forrest v Australian Securities and Investments Commission (2012) 247 CLR 486
GlaxoSmithKline Australia Pty Ltd v Pharmacor Pty Ltd [2014] FCA 1202
Google Inc v Australian Competition and Consumer Commission (2013) 249 CLR 435
Miller & Associates Insurance Broking Pty Ltd v BMW Australia Finance Ltd (2010) 241 CLR 357
ObjectiVision Pty Ltd v Visionsearch Pty Ltd [2014] FCA 1087
Optiver Australia Pty Ltd v Tibra Trading Pty Ltd (2008) 169 FCR 435
Reeve v Aqualast Pty Ltd [2012] FCA 679
Specsavers Pty Ltd v Canstar Blue Pty Ltd [2010] FCA 1153
St George Bank Ltd v Rabo Australia Ltd (2004) 211 ALR 147
Date of hearing: 19 August 2015
Date of last submissions: 26 August 2015
Place: Melbourne
Division: GENERAL DIVISION
Category: Catchwords
Number of paragraphs: 60
Counsel for the Prospective Applicant: Mr L A Merrick
Solicitor for the Prospective Applicant: Corrs Chambers Westgarth
Counsel for the Prospective Respondent: Ms C Cochrane with Ms F St John
Solicitor for the Prospective Respondent: Russells

IN THE FEDERAL COURT OF AUSTRALIA

VICTORIA DISTRICT REGISTRY

GENERAL DIVISION

VID 285 of 2015

BETWEEN:

L’ORÉAL AUSTRALIA PTY LTD (ABN 40 004 191 673)
Prospective Applicant

AND:

BRANDPOINT PTY LTD (ABN 12 135 694 718)
Prospective Respondent

JUDGE:

BEACH J

DATE OF ORDER:

4 SEPTEMBER 2015

WHERE MADE:

MELBOURNE

THE COURT ORDERS THAT:

The Court notes the confidentiality undertaking in the form annexed and marked “A” in relation to documents to be discovered pursuant to order 1 below which are designated as confidential by the Prospective Respondent (“the proposed confidentiality undertaking”).

THE COURT ORDERS THAT:

1.By 4.00 pm on 30 September 2015, the Prospective Respondent…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read L'Oréal Australia Pty Ltd v BrandPoint Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2015] FCA 978
Decision Date

CaseChat Overview and Summary

L'Oréal Australia Pty Ltd sought an order for preliminary discovery from BrandPoint Pty Ltd in relation to the distribution and marketing of facial cleansing products. BrandPoint was the exclusive distributor of the Clarisonic products in Australia and New Zealand until 2012. The case centred on BrandPoint's alleged misleading or deceptive conduct in marketing its PuraSonic product, potentially contravening sections 18 and 29 of the Australian Consumer Law. The court was required to determine whether L'Oréal had a reasonable belief that BrandPoint had contravened the ACL, and if L'Oréal had conducted reasonable inquiries. Additionally, the court had to decide whether the potential right to relief arising from the alleged contraventions was sufficient to justify the grant of preliminary discovery. The court concluded that L'Oréal's belief was reasonable, and that it had made sufficient inquiries to warrant the grant of preliminary discovery concerning BrandPoint's email representations. However, the application relating to BrandPoint's website representations was dismissed as it lacked substance. The court ordered BrandPoint to provide specific documents to L'Oréal, with certain confidentiality provisions, and outlined the costs implications of further proceedings.

Orders

Orders of the court

1. By 4.00 pm on 30 September 2015, the Prospective Respondent give discovery to the Prospective Applicant of the following documents:

(a) All documents which record or evidence:

(i) the method, process and any assumptions used in; and

(ii) the results of,

any trials, testing or analysis conducted by, for or on behalf of, the Prospective Respondent in relation to the claims made in the impugned representations.

(b) All advertising and promotional material relating to the PuraSonic product containing any of the impugned representations, along with any correspondence by which that material was distributed.

(c) All documents recording or evidencing the identity of the recipients of the advertising and promotional material referred to in paragraph (b).

In these categories of documents:

· advertising and promotional material is limited to material disclosed by the Prospective Respondent to any third party in Australia;

· impugned representations means the representations in relation to the PuraSonic product referred to in paragraph 34 of the affidavit of Vincent Lo affirmed 29 May 2015.

2. Subject to further order, to the extent that any discovery given by the Prospective Respondent is designated as confidential, then any recipient thereof shall give to the Prospective Respondent an undertaking to the effect of the proposed confidentiality undertaking.

3. If within 60 days of the date of this order, the Prospective Applicant has instituted proceedings against the Prospective Respondent in relation to the impugned representations, then the parties’ costs of and incidental to this application shall be treated as their costs in that cause.

4. If within 60 days of the date of this order, no such proceeding has been commenced, then each party shall bear their own costs of and incidental to this application.

5. Subject to order 6, the Prospective Applicant shall pay the Prospective Respondent’s costs of and in relation to giving the discovery referred to in order 1, such costs to be taxed (if not agreed) and paid forthwith.

6. If the Prospective Applicant institutes proceedings of the type referred to in order 3, any costs that it has paid or will pay under order 5 shall be treated as and added to its costs in that cause.

7. Liberty to apply.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

In my view, preliminary discovery should be given by BrandPoint concerning the BrandPoint email representations. There is no substance to L’Oréal Australia’s application concerning the BrandPoint website representations.BACKGROUND The Clarisonic product was launched in the USA in 2004 by Pacific Bioscience Laboratories Inc (PBL). Over the next seven years, the Clarisonic range was expanded to include various models of the sonic facial cleansing brush (including the “Mia 2” and the “Aria”), skincare cleansers and masks, replacement brush heads and chargers (the Clarisonic products). PBL distributed, advertised, promoted, offered for sale and sold the Clarisonic products in the USA, Canada, Europe and the Asia Pacific region including Australia and New Zealand. PBL also conducted studies to test the effectiveness of the Clarisonic products. In or about November 2010, PBL appointed BrandPoint as its exclusive distributor of the Clarisonic products in Australia and New Zealand pursuant to a distribution agreement (the distribution agreement). BrandPoint, a company based in Queensland, was founded in 2008 by Mr McCarthy. It had an annual turnover of approximately $11 million and the equivalent of 20 full-time employees. It distributed beauty, fragrance, health and personal care goods in Australia to department stores, pharmacies and online retailers. As exclusive distributor, BrandPoint received information from time to time about the Clarisonic products including technical and marketing material. In 2011 L’Oréal SA (L’Oréal), a French company, acquired PBL including all rights and trade marks in relation to the Clarisonic products. L’Oréal is L’Oréal Australia’s parent company. The distribution agreement expired in November 2012. In anticipation thereof, PBL had sent a letter to BrandPoint on 27 June 2012 confirming the transition details including:(a)provision of the Clarisonic customer database by BrandPoint to L’Oréal Australia to facilitate ongoing customer service;(b)return by BrandPoint of Clarisonic marketing and communication materials, samples and supplies; and(c)collaboration on mutual communications including “co-visits with the L’Oréal team” to retail partners. Since the expiry of the distribution agreement, L’Oréal Australia has imported, warehoused, marketed, sold and distributed the Clarisonic products in Australia and, later, in New Zealand. L’Oréal Australia was incorporated in Australia in 1934. It currently employs more than 700 employees throughout Australia and has offices in Melbourne and Sydney and distribution centres in Dandenong South and Perth. For many decades L’Oréal Australia has distributed numerous personal care products in Australia including from brands such as Lancôme, Giorgio Armani beauty, YvesSaintLaurent Beauté and Ralph Lauren fragrances. Its Clarisonic products are sold in department stores, pharmacies and online. The Clarisonic products have dominated the market for sonic facial cleansing brushes since their launch in Australia in 2010. It is only BrandPoint’s PuraSonic product that has posed any real threat to the Clarisonic products in the Australian market.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.